Proteome- and Transcriptome-Driven Reconstruction of the Human Myocyte Metabolic Network and Its Use for Identification of Markers for Diabetes

Cell Reports

Volumn 11, Issue 6, 2015, Pages 921-933

  Väremo, Leif ^a   Scheele, Camilla ^b,c   Broholm, Christa ^b   Mardinoglu, Adil ^a   Kampf, Caroline ^d   Asplund, Anna ^d   Nookaew, Intawat ^a,g   Uhlén, Mathias ^e,f   Pedersen, BenteKlarlund ^b   Nielsen, Jens ^a,f  

^a CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Capital Region   (Denmark)

^d UPPSALA UNIVERSITY   (Sweden)

^e ALBANOVA UNIVERSITY CENTER   (Sweden)

^f ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^g OAK RIDGE NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROLIPOAMIDE DEHYDROGENASE; PROTEOME; PYRUVIC ACID; TRANSCRIPTOME; BIOLOGICAL MARKER;

ADULT; AGED; AMINO ACID METABOLISM; ARTICLE; CATABOLISM; CELL METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MALE; MUSCLE CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RNA SEQUENCE; TRANSCRIPTION REGULATION; BIOLOGICAL MODEL; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; META ANALYSIS (TOPIC); METABOLISM; MIDDLE AGED; REPRODUCIBILITY; SEQUENCE ANALYSIS;

AGED; BIOMARKERS; DIABETES MELLITUS, TYPE 2; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; META-ANALYSIS AS TOPIC; METABOLIC NETWORKS AND PATHWAYS; MIDDLE AGED; MODELS, BIOLOGICAL; MUSCLE CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEOME; REPRODUCIBILITY OF RESULTS; SEQUENCE ANALYSIS, RNA; TRANSCRIPTOME;

EID: 84929276343     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.04.010     Document Type: Article

References (60)

1. Abdul-Ghani M.A., DeFronzo R.A. Pathogenesis of insulin resistance in skeletal muscle. J.Biomed. Biotechnol. 2010, 2010:476279.
2. Agren R., Bordel S., Mardinoglu A., Pornputtapong N., Nookaew I., Nielsen J. Reconstruction of genome-scale active metabolic networks for 69 human cell types and 16 cancer types using INIT. PLoS Comput. Biol. 2012, 8:e1002518.
3. Agren R., Liu L., Shoaie S., Vongsangnak W., Nookaew I., Nielsen J. The RAVEN toolbox and its use for generating a genome-scale metabolic model for Penicillium chrysogenum. PLoS Comput. Biol. 2013, 9:e1002980.
4. Agren R., Mardinoglu A., Asplund A., Kampf C., Uhlen M., Nielsen J. Identification of anticancer drugs for hepatocellular carcinoma through personalized genome-scale metabolic modeling. Mol. Syst. Biol. 2014, 10:721.
5. Anders S., Pyl P.T., Huber W. HTSeq-a Python framework to work with high-throughput sequencing data. Bioinformatics 2015, 31:166-169.
6. Bergström J. Percutaneous needle biopsy of skeletal muscle in physiological and clinical research. Scand. J. Clin. Lab. Invest. 1975, 35:609-616.
7. Bordbar A., Feist A.M., Usaite-Black R., Woodcock J., Palsson B.O., Famili I. A multi-tissue type genome-scale metabolic network for analysis of whole-body systems physiology. BMC Syst. Biol. 2011, 5:180.
8. Bordbar A., Monk J.M., King Z.A., Palsson B.O. Constraint-based models predict metabolic and associated cellular functions. Nat. Rev. Genet. 2014, 15:107-120.
9. Boushel R., Gnaiger E., Schjerling P., Skovbro M., Kraunsøe R., Dela F. Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia 2007, 50:790-796.
10. Broholm C., Brandt C., Schultz N.S., Nielsen A.R., Pedersen B.K., Scheele C. Deficient leukemia inhibitory factor signaling in muscle precursor cells from patients with type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 2012, 303:E283-E292.
11. Chen L., Magliano D.J., Zimmet P.Z. The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives. Nat. Rev. Endocrinol. 2012, 8:228-236.
12. Chibalin A.V., Leng Y., Vieira E., Krook A., Björnholm M., Long Y.C., Kotova O., Zhong Z., Sakane F., Steiler T., et al. Downregulation of diacylglycerol kinase delta contributes to hyperglycemia-induced insulin resistance. Cell 2008, 132:375-386.
13. Choi J.K., Yu U., Kim S., Yoo O.J. Combining multiple microarray studies and modeling interstudy variation. Bioinformatics 2003, 19(Suppl 1):i84-i90.
14. De Feyter H.M., van den Broek N.M.A., Praet S.F.E., Nicolay K., van Loon L.J.C., Prompers J.J. Early or advanced stage type 2 diabetes is not accompanied by invivo skeletal muscle mitochondrial dysfunction. Eur. J. Endocrinol. 2008, 158:643-653.
15. Dobin A., Davis C.A., Schlesinger F., Drenkow J., Zaleski C., Jha S., Batut P., Chaisson M., Gingeras T.R. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 2013, 29:15-21.
16. Donath M.Y., Shoelson S.E. Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 2011, 11:98-107.
17. Edgar R., Domrachev M., Lash A.E. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002, 30:207-210.
18. Fagerberg L., Hallström B.M., Oksvold P., Kampf C., Djureinovic D., Odeberg J., Habuka M., Tahmasebpoor S., Danielsson A., Edlund K., et al. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol. Cell. Proteomics 2014, 13:397-406.
19. Frederiksen C.M., Højlund K., Hansen L., Oakeley E.J., Hemmings B., Abdallah B.M., Brusgaard K., Beck-Nielsen H., Gaster M. Transcriptional profiling of myotubes from patients with type 2 diabetes: no evidence for a primary defect in oxidative phosphorylation genes. Diabetologia 2008, 51:2068-2077.
20. Gallagher I.J., Scheele C., Keller P., Nielsen A.R., Remenyi J., Fischer C.P., Roder K., Babraj J., Wahlestedt C., Hutvagner G., et al. Integration of microRNA changes invivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes. Genome Med. 2010, 2:9.
21. Green C.J., Pedersen M., Pedersen B.K., Scheele C. Elevated NF-κB activation is conserved in human myocytes cultured from obese type 2 diabetic patients and attenuated by AMP-activated protein kinase. Diabetes 2011, 60:2810-2819.
22. Hebenstreit D., Fang M., Gu M., Charoensawan V., van Oudenaarden A., Teichmann S.A. RNA sequencing reveals two major classes of gene expression levels in metazoan cells. Mol. Syst. Biol. 2011, 7:497.
23. Jin W., Goldfine A.B., Boes T., Henry R.R., Ciaraldi T.P., Kim E.-Y., Emecan M., Fitzpatrick C., Sen A., Shah A., et al. Increased SRF transcriptional activity in human and mouse skeletal muscle is a signature of insulin resistance. J.Clin. Invest. 2011, 121:918-929.
24. Kimura K., Nakamura Y., Inaba Y., Matsumoto M., Kido Y., Asahara S., Matsuda T., Watanabe H., Maeda A., Inagaki F., et al. Histidine augments the suppression of hepatic glucose production by central insulin action. Diabetes 2013, 62:2266-2277.
25. Lee Y.T., Hsu C.C., Lin M.H., Liu K.S., Yin M.C. Histidine and carnosine delay diabetic deterioration in mice and protect human low density lipoprotein against oxidation and glycation. Eur. J. Pharmacol. 2005, 513:145-150.
26. Lefort N., Glancy B., Bowen B., Willis W.T., Bailowitz Z., De Filippis E.A., Brophy C., Meyer C., Højlund K., Yi Z., Mandarino L.J. Increased reactive oxygen species production and lower abundance of complex I subunits and carnitine palmitoyltransferase 1B protein despite normal mitochondrial respiration in insulin-resistant human skeletal muscle. Diabetes 2010, 59:2444-2452.
27. Lorenz T., Campello M. Biomechanics of skeletal muscle. Basic Biomechanics of the Musculoskeletal System 2001, 148-174. Lippincott Williams & Wilkins, Philadelphia. Third Edition. M. Nordin, V.H. Frankel (Eds.).
28. Lundberg E., Fagerberg L., Klevebring D., Matic I., Geiger T., Cox J., Algenäs C., Lundeberg J., Mann M., Uhlen M. Defining the transcriptome and proteome in three functionally different human cell lines. Mol. Syst. Biol. 2010, 6:450.
29. Lynch C.J., Adams S.H. Branched-chain amino acids in metabolic signalling and insulin resistance. Nat. Rev. Endocrinol. 2014, 10:723-736.
30. Mardinoglu A., Agren R., Kampf C., Asplund A., Nookaew I., Jacobson P., Walley A.J., Froguel P., Carlsson L.M., Uhlen M., Nielsen J. Integration of clinical data with a genome-scale metabolic model of the human adipocyte. Mol. Syst. Biol. 2013, 9:649.
31. Mardinoglu A., Gatto F., Nielsen J. Genome-scale modeling of human metabolism - a systems biology approach. Biotechnol. J. 2013, 8:985-996.
32. Mardinoglu A., Agren R., Kampf C., Asplund A., Uhlen M., Nielsen J. Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease. Nat. Commun. 2014, 5:3083.
33. Møller J.B., Pedersen M., Tanaka H., Ohsugi M., Overgaard R.V., Lynge J., Almind K., Vasconcelos N.-M., Poulsen P., Keller C., et al. Body composition is the main determinant for the difference in type 2 diabetes pathophysiology between Japanese and Caucasians. Diabetes Care 2014, 37:796-804.
34. Mootha V.K., Lindgren C.M., Eriksson K.F., Subramanian A., Sihag S., Lehar J., Puigserver P., Carlsson E., Ridderstråle M., Laurila E., et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 2003, 34:267-273.
35. Nagaraj N., Wisniewski J.R., Geiger T., Cox J., Kircher M., Kelso J., Pääbo S., Mann M. Deep proteome and transcriptome mapping of a human cancer cell line. Mol. Syst. Biol. 2011, 7:548.
36. Patil K.R., Nielsen J. Uncovering transcriptional regulation of metabolism by using metabolic network topology. Proc. Natl. Acad. Sci. USA 2005, 102:2685-2689.
37. Patti M.E., Butte A.J., Crunkhorn S., Cusi K., Berria R., Kashyap S., Miyazaki Y., Kohane I., Costello M., Saccone R., et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc. Natl. Acad. Sci. USA 2003, 100:8466-8471.
38. Pedersen B.K., Febbraio M.A. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat. Rev. Endocrinol. 2012, 8:457-465.
39. Petropoulos S., Guillemin C., Ergaz Z., Dimov S., Suderman M., Weinstein-Fudim L., Ornoy A., Szyf M. Gestational diabetes alters offspring DNA methylation profiles in human and rat: identification of key pathways involved in endocrine system disorders, insulin signaling, diabetes signaling and IL-K signaling. Endocrinology 2014, Published online December 16, 2014. 10.1210/en.2014-1643.
40. Pihlajamäki J., Lerin C., Itkonen P., Boes T., Floss T., Schroeder J., Dearie F., Crunkhorn S., Burak F., Jimenez-Chillaron J.C., et al. Expression of the splicing factor gene SFRS10 is reduced in human obesity and contributes to enhanced lipogenesis. Cell Metab. 2011, 14:208-218.
41. Ramakrishnan S.R., Vogel C., Prince J.T., Li Z., Penalva L.O., Myers M., Marcotte E.M., Miranker D.P., Wang R. Integrating shotgun proteomics and mRNA expression data to improve protein identification. Bioinformatics 2009, 25:1397-1403.
42. Ramasamy A., Mondry A., Holmes C.C., Altman D.G. Key issues in conducting a meta-analysis of gene expression microarray datasets. PLoS Med. 2008, 5:e184.
43. Robinson M.D., McCarthy D.J., Smyth G.K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 2010, 26:139-140.
44. Rustici G., Kolesnikov N., Brandizi M., Burdett T., Dylag M., Emam I., Farne A., Hastings E., Ison J., Keays M., et al. ArrayExpress update-trends in database growth and links to data analysis tools. Nucleic Acids Res. 2013, 41:D987-D990.
45. Scheele C., Nielsen S., Kelly M., Broholm C., Nielsen A.R., Taudorf S., Pedersen M., Fischer C.P., Pedersen B.K. Satellite cells derived from obese humans with type 2 diabetes and differentiated into myocytes invitro exhibit abnormal response to IL-6. PLoS ONE 2012, 7:e39657.
46. Schwanhäusser B., Busse D., Li N., Dittmar G., Schuchhardt J., Wolf J., Chen W., Selbach M. Global quantification of mammalian gene expression control. Nature 2011, 473:337-342.
47. Sears D.D., Hsiao G., Hsiao A., Yu J.G., Courtney C.H., Ofrecio J.M., Chapman J., Subramaniam S. Mechanisms of human insulin resistance and thiazolidinedione-mediated insulin sensitization. Proc. Natl. Acad. Sci. USA 2009, 106:18745-18750.
48. Shin A.C., Fasshauer M., Filatova N., Grundell L.A., Zielinski E., Zhou J.Y., Scherer T., Lindtner C., White P.J., Lapworth A.L., et al. Brain insulin lowers circulating BCAA levels by inducing hepatic BCAA catabolism. Cell Metab. 2014, 20:898-909.
49. Stancáková A., Civelek M., Saleem N.K., Soininen P., Kangas A.J., Cederberg H., Paananen J., Pihlajamäki J., Bonnycastle L.L., Morken M.A., et al. Hyperglycemia and a common variant of GCKR are associated with the levels of eight amino acids in 9,369 Finnish men. Diabetes 2012, 61:1895-1902.
50. Stump C.S., Henriksen E.J., Wei Y., Sowers J.R. The metabolic syndrome: role of skeletal muscle metabolism. Ann. Med. 2006, 38:389-402.
51. Szendroedi J., Phielix E., Roden M. The role of mitochondria in insulin resistance and type 2 diabetes mellitus. Nat. Rev. Endocrinol. 2012, 8:92-103.
52. Trapnell C., Williams B.A., Pertea G., Mortazavi A., Kwan G., van Baren M.J., Salzberg S.L., Wold B.J., Pachter L. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 2010, 28:511-515.
53. Uhlen M., Oksvold P., Fagerberg L., Lundberg E., Jonasson K., Forsberg M., Zwahlen M., Kampf C., Wester K., Hober S., et al. Towards a knowledge-based Human Protein Atlas. Nat. Biotechnol. 2010, 28:1248-1250.
54. van Tienen F.H.J., Praet S.F.E., de Feyter H.M., van den Broek N.M., Lindsey P.J., Schoonderwoerd K.G.C., de Coo I.F.M., Nicolay K., Prompers J.J., Smeets H.J.M., van Loon L.J. Physical activity is the key determinant of skeletal muscle mitochondrial function in type 2 diabetes. J.Clin. Endocrinol. Metab. 2012, 97:3261-3269.
55. Väremo L., Nielsen J., Nookaew I. Enriching the gene set analysis of genome-wide data by incorporating directionality of gene expression and combining statistical hypotheses and methods. Nucleic Acids Res. 2013, 41:4378-4391.
56. Väremo L., Nookaew I., Nielsen J. Novel insights into obesity and diabetes through genome-scale metabolic modeling. Front. Physiol. 2013, 4:92.
57. Väremo L., Gatto F., Nielsen J. Kiwi: a tool for integration and visualization of network topology and gene-set analysis. BMC Bioinformatics 2014, 15:408.
58. Vogel C., Marcotte E.M. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat. Rev. Genet. 2012, 13:227-232.
59. Wang Y., Eddy J.A., Price N.D. Reconstruction of genome-scale metabolic models for 126 human tissues using mCADRE. BMC Syst. Biol. 2012, 6:153.
60. Yoshihara K., Shahmoradgoli M., Martínez E., Vegesna R., Kim H., Torres-Garcia W., Treviño V., Shen H., Laird P.W., Levine D.A., et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 2013, 4:2612.